Old Web
English
Sign In
Acemap
>
authorDetail
>
R Wang
R Wang
Daiichi Sankyo
Atrial fibrillation
Medicine
Internal medicine
Edoxaban
Rivaroxaban
4
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Comparison of clinical outcomes of edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonists in patients with atrial fibrillation in Germany: A real-world cohort study
2021
International Journal of Cardiology
X.L Marston
R Wang
Y C Yeh
L Zimmermann
X. Ye
X. Gao
B. Brüggenjürgen
Martin Unverdorben
Show All
Source
Cite
Save
Citations (0)
Effectiveness and safety of edoxaban in atrial fibrillation patients from the ETNA-AF global registry
2021
European Heart Journal
R. De Caterina
R Wang
L. Shi
Ladislav Pecen
X. Ye
P.E. Reimitz
Cathy Chen
Martin Unverdorben
Robert P. Giugliano
Show All
Source
Cite
Save
Citations (0)
Improved adherence to anticoagulant therapy with once-daily regimen: a real-world study in patients with atrial fibrillation in Germany
2020
European Heart Journal
Y C Yeh
R Wang
X.L Marston
L Zimmermann
X. Ye
X. Gao
Show All
Source
Cite
Save
Citations (1)
Comparison of clinical outcomes with edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonist in patients with atrial fibrillation in Germany: a real-world cohort study
2020
European Heart Journal
X.L Marston
R Wang
Y C Yeh
L Zimmermann
X. Ye
X. Gao
Martin Unverdorben
Show All
Source
Cite
Save
Citations (1)
1